About
Sionna Therapeutics, Inc. Common Stock (NASDAQ:SION) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 27 2026
Sionna Therapeutics Completes Enrollment in PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, Added to Standard of Care in Participants with Cystic Fibrosis
Apr 7 2026
Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium
Mar 2 2026
Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Feb 23 2026
Sionna Therapeutics to Participate in Upcoming March 2026 Investor Conferences
Feb 4 2026
Sionna Therapeutics to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026
Financials
Revenue
$0
Market Cap
$1.82 B
EPS
-1.88
Google Übersetzer